Eterna Therapeutics
ERNA
₹197.08
Share price
-3.38%
Change (1 day)
22.86%
Change (1 year)
Categories
Earnings for Eterna Therapeutics (ERNA)
Earnings in 2025 (TTM): -₹2.91 Billion
According to Eterna Therapeutics's latest financial reports the company's current earnings are ₹0.53 Million. In 2024 the company made an earning of -₹3.25 Billion a decrease over its 2023 earnings that were of -₹1.77 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Eterna Therapeutics from 2020 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -₹2.91 Billion | -10.37% |
| 2024 | -₹3.25 Billion | 83.64% |
| 2023 | -₹1.77 Billion | -16.24% |
| 2022 | -₹2.11 Billion | -80.08% |
| 2021 | -₹10.59 Billion | 1596.7% |
| 2020 | -₹0.63 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Baxter BAX | -₹61.28 Billion | 1,956.02% | 🇺🇸 USA |
 Geron GERN | -₹9.97 Billion | 234.24% | 🇺🇸 USA |
 Omeros Corporation OMER | -₹13.45 Billion | 351.19% | 🇺🇸 USA |
 Sanofi SNY | ₹755.65 B | -25,454.98% | 🇫🇷 France |
 Bio-Techne TECH | ₹14.78 B | -596.17% | 🇺🇸 USA |
 Genetic Technologies GENE | -₹0.34 Billion | -88.84% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | ₹39.07 B | -1,411.00% | 🇮🇱 Israel |